Nanobac Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	2002
Period Ending	Mar '26 Mar 2, 2026	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	2002
Market Capitalization	0	12	23	7	27	57	Upgrade
Market Cap Growth	-99.80%	-48.97%	232.85%	-74.05%	-52.71%	-	Upgrade
Enterprise Value	-	16	28	9	27	58	Upgrade
Last Close Price	0.00	0.05	0.12	0.04	0.14	0.69	Upgrade
PS Ratio	0.01	674.12	103.41	10.65	75.20	118.03	Upgrade
PB Ratio	0.00	-5.03	-17.75	2.84	4.41	-70.69	Upgrade
EV/Sales Ratio	-	896.31	123.69	13.51	75.30	119.76	Upgrade
Debt / Equity Ratio	-1.74	-1.74	-4.09	1.01	0.04	-7.11	Upgrade
Net Debt / Equity Ratio	-1.74	-1.74	-4.06	1.00	0.04	-7.05	Upgrade
Net Debt / EBITDA Ratio	-1.04	-1.04	-1.44	-1.19	-0.04	-2.25	Upgrade
Net Debt / FCF Ratio	-4.51	-4.51	-2.05	-1.03	-0.07	-2.61	Upgrade
Asset Turnover	0.00	0.00	0.03	0.07	0.04	0.12	Upgrade
Inventory Turnover	0.38	0.38	0.87	2.44	2.32	-	Upgrade
Quick Ratio	0.00	0.00	0.01	0.00	0.02	0.01	Upgrade
Current Ratio	0.01	0.01	0.02	0.05	0.09	0.01	Upgrade
Return on Equity (ROE)	-	-	-862.64%	-86.00%	-319.01%	-	Upgrade
Return on Assets (ROA)	-36.84%	-36.84%	-31.48%	-19.02%	-52.99%	-40.92%	Upgrade
Return on Capital Employed (ROCE)	-934.90%	-934.90%	-277.40%	-53.50%	-90.70%	-193.70%	Upgrade
Earnings Yield	-2630444.40%	-55.36%	-21.37%	-52.73%	-31.61%	-6.49%	Upgrade
FCF Yield	-364967.60%	-7.68%	-11.16%	-34.40%	-12.74%	-3.81%	Upgrade
Buyback Yield / Dilution	-22.95%	-22.95%	-4.62%	-24.67%	-126.56%	-384.10%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.